Dr. Sandra Violetta Mele, DO

Dr. Mele practices at HonorHealth Four Peaks Medical Center in Mesa, Arizona, part of HonorHealth.

Dr. Mele's NPI, 1265811418, was assigned on May 20, 2015. Dr. Mele holds Arizona license 007514.

Dr. Mele's primary practice is HonorHealth Four Peaks Medical Center, at 1301 South Crismon Road, Mesa, AZ 85209 in Maricopa County. The practice phone is (480) 358-6100.

Dr. Mele's primary practice is HonorHealth Four Peaks Medical Center in Mesa, Arizona, part of HonorHealth. Dr. Mele is also affiliated with HonorHealth Tempe Medical Center. The medical group on file is HonorHealth Medical Group. Dmand AI also links Dr. Mele to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mele practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mele's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mele is licensed in Arizona.

CMS data shows 479 Medicare services from Dr. Mele across 5 procedure codes in 2024, for 193 Medicare patients. Medicare paid $44,470 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 193 Medicare patients who saw Dr. Mele in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mele's median patient age at 68, with 52% women.

In 2024, Dr. Mele wrote 102 Medicare Part D claims for 43 patients. 88% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $142 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

Dr. Mele accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Dr. Mele from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 91% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $198.